DR. MICHAEL STEVEN DIGBY M.D. NPI 1871758938

NPI Details

DR. Michael Steven Digby, M.D. is a dermatology in Fort Payne, AL with 18 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. DR. Michael Steven Digby, M.D. NPI is 1871758938. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIFORMED SERVICES UHS FE HEBERT SCHOOL OF MED
Graduation Year:2008

The provider's business location address is:

212 AIRPORT RD W
FORT PAYNE, AL
ZIP 35968
Phone: (256) 979-1250
Fax: (256) 979-1251

The NPI 1871758938 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Ultrasonic guidance for placement of radiation therapy fields (HCPCS:G6001)
• Superficial and/or low voltage radiation treatment delivery (HCPCS:77401)
• Obtaining data needed to develop the optimal radiation treatment, 1 treatment area (HCPCS:77280)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Radiation treatment management, 5 treatment sessions (HCPCS:77427)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks (HCPCS:17311)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Continuing radiation therapy consultation per week (HCPCS:77336)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Punch biopsy, first skin growth (HCPCS:11104)
• Calculation of radiation therapy dose (HCPCS:77300)
• Pathology examination of specimen during surgery, first tissue block (HCPCS:88331)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm (HCPCS:12052)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks (HCPCS:17312)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less (HCPCS:12051)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Biopsy of ear (HCPCS:69100)
• Simple radiation therapy planning (HCPCS:77261)
• Design and construction of complex radiation treatment device (HCPCS:77334)
• Design and construction of simple radiation treatment device (HCPCS:77332)
• Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) (HCPCS:J7308)
• Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks (HCPCS:17313)
• Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11603)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm (HCPCS:12042)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Application of light to destroy precancer skin growth (HCPCS:96567)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Punch biopsy, each additional skin growth (HCPCS:11105)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:17282)
• Complex radiation therapy planning (HCPCS:77263)
• Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm (HCPCS:13151)
• Incision biopsy, first skin growth (HCPCS:11106)
• Intermediate radiation therapy planning (HCPCS:77262)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• Obtaining data needed to develop the optimal radiation treatment, 2 treatment areas (HCPCS:77285)
• Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm (HCPCS:11604)
• Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved (HCPCS:77290)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 7/28/2008 and was last updated on 6/4/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.